27 August 2025 : Clinical Research
Diabetes, Inflammatory Markers, and Tissue Thickness in Septic and Aseptic Hip Revision Surgeries
Mücahid Osman Yücel
ABEF 1*, Raşit Emin Dalaslan EF 1, Sönmez Sağlam BD 1, Mehmet Arıcan BE 1, Zekeriya Okan Karaduman E 1, Mücahit Çelik C 2, Mehmet Akif Kose DF 3, Emre Arıkan F 4
DOI: 10.12659/MSM.949619
Med Sci Monit 2025; 31:e949619
Table 1 Demographic and clinical data of patients undergoing revision hip arthroplasty.
| Parameter | Value |
|---|---|
| Age (years) (Mean±SD) | 60.44±9.54 |
| Gender, n (%) | |
| Female | 33 (67.3) |
| Male | 16 (32.7) |
| Side, n (%) | |
| Right | 25 (51.0) |
| Left | 24 (49.0) |
| Comorbidities, n (%) | 43 (87.8) |
| DM, n (%) | 18 (36.7) |
| Loosening, n (%) | |
| Aseptic loosening | 34 (69.4) |
| Septic loosening | 15 (30.6) |
| First surgery Tönnis Hip Osteoarthritis Classification, n (%) | |
| Grade 2 | 27 (55.1) |
| Grade 3 | 18 (36.7) |
| None (Femoral Neck Fracture) | 4 (8.2) |
| Revision surgery diagnosis, n (%) | |
| Aseptic loosening | 19 (38.8) |
| Acetabular cup protrusion | 1 (2.0) |
| Dislocation | 10 (20.4) |
| Periprosthetic fracture | 3 (6.1) |
| Protruded acetabular cup | 1 (2.0) |
| Septic loosening | 15 (30.6) |
| Type of RHA, n (%) | |
| Acetabular cup revision | 4 (8.2) |
| RTHA | 35 (71.4) |
| Spacer removal + RTHA | 10 (20.4) |
| Preoperative ESR, Median (Min–Max) | 19 (3–107) |
| Preoperative CRP, Median (Min–Max) | 0.57 (0.04–16.86) |
| Soft tissue thickness, Median (Min–Max) | 42 (18–130) |
| Revision operation duration (min) (Mean±SD) | 214.39±78.78 |
| Number of blood transfusions (units) | 2 (0–8) |
| Postoperative culture positive, n (%) | 9 (28.1) |
| Mortality, n (%) | 4 (8.2) |
| DM – diabetes mellitus; RTHA – revision total hip arthroplasty; ESR – erythrocyte sedimentation rate; CRP – C-reactive protein; mean±SD – arithmetic mean with standard deviation; Median (Min–Max) – median value with the minimum and maximum range; n (%) – number of patients (percentage). | |